Aimei Health Technology Co., Ltd
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Junheng Xie
- Full Time Employees
- 2
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 10 East 53rd Street New York City NY United States of America 10022
- IPO Date
- Jan 22, 2024
- CIK
- 0001979005
- Website
- aimeihealth.com
- Similar Companies
- Business
- Aimei Health Technology Co., Ltd, a Cayman Islands-incorporated blank check company founded on April 27, 2023 and headquartered at 10 East 53rd Street, Suite 3001, New York, NY, focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses, primarily targeting small-cap entities in the biopharmaceutical, medical technology/device, diagnostic, and related services sectors across North America, Europe, and Asia Pacific regions. The company currently conducts no significant operations and generates no revenue, relying instead on interest income from its Trust Account holding approximately $44.5 million as of June 30, 2025 to cover formation, operating, and transaction pursuit costs. In June 2024, it entered into a definitive Business Combination Agreement with United Hydrogen Group Inc., a Cayman Islands exempted company providing comprehensive hydrogen solutions in China including production, storage, transportation, refueling stations, and end-user applications; the proposed transaction, valued at a pro forma equity of about $1.6 billion and originally targeting a Q3 2024 close, remains pending as of mid-2025 amid multiple extensions of the combination deadline to September 6, 2025 via monthly Trust Account deposits totaling over $927,700 from the sponsor and target, alongside 2.9 million public shares redeemed in February 2025 for $31.3 million.
AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED QUARTERLY REPORT
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED QUARTERLY REPORT
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED ANNUAL REPORT
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED ANNUAL REPORT
Aimei Health Technology (NASDAQ:AFJK) Stock Price Up 0.4% – Should You Buy?
Aimei Health Technology (NASDAQ:AFJK) Shares Gap Up – Still a Buy?
Aimei Health Technology (NASDAQ:AFJK) Hits New 52-Week High – Time to Buy?
Aimei Health (AFJK) Is Trending: Shares Soar Over 1,000% Before Dropping In After-Hours Trading
AFJK Stock: 5 Things to Know as a United Hydrogen SPAC Merger Takes Shape